FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shantaram Joshi

Research Profile

Living Beings

Anatomy

Disorders

Physiology

Procedures

Chemicals & Drugs

Proanthocyanidins

Co-author Network

Publications

TOP 3
Ganapati V Hegde; Philip J Bierman; Amit K Mittal; Corey M Munger; Tara M Nordgren; J Graham Sharp; Julie M Vose; Dennis D Weisenburger; Shantaram S Joshi
Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signaling.
Adam K Ahrens; Nagendra K Chaturvedi; Bhavana J Dave; Tara M Nordgren; Shantaram S Joshi
Establishment and characterization of therapy-resistant mantle cell lymphoma cell lines derived from different tissue sites.
Corey M Munger; Julie M Vose; Dennis D Weisenburger; Ganapati V Hegde; Shantaram S Joshi
Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shantaram Joshi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ganapati V Hegde; Philip J Bierman; Amit K Mittal; Corey M Munger; Tara M Nordgren; J Graham Sharp; Julie M Vose; Dennis D Weisenburger; Shantaram S Joshi
Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signaling.
International journal of cancer. Journal international du cancer 2012;131(12):2951-60.
2012: Adam K Ahrens; Nagendra K Chaturvedi; Bhavana J Dave; Tara M Nordgren; Shantaram S Joshi
Establishment and characterization of therapy-resistant mantle cell lymphoma cell lines derived from different tissue sites.
Leukemia & lymphoma 2012;53(11):2269-78.
2012: Corey M Munger; Julie M Vose; Dennis D Weisenburger; Ganapati V Hegde; Shantaram S Joshi
Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma.
Cancer immunology, immunotherapy : CII 2012;61(10):1819-32.
2012: Christine E Gilling; Javeed Iqbal; Amit K Mittal; Dennis D Weisenburger; Patricia Aoun; Philip J Bierman; R Gregory Bociek; Nagendra K Chaturvedi; Shantaram S Joshi
Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1.
British journal of haematology 2012;158(2):216-31.
2011: William Trickler; Daniel J Munt; Neha Jain; Shantaram S Joshi; Alekha K Dash
Antitumor efficacy, tumor distribution and blood pharmacokinetics of chitosan/glyceryl-monooleate nanostructures containing paclitaxel.
Nanomedicine (London, England) 2011;6(3):437-48.
2011: Simanta Pathak; Long Trinh; Kay-Uwe Wagner; James Eudy; Shantaram S Joshi; Shibin Ma; Runqing Lu
IRF4 is a suppressor of c-Myc induced B cell leukemia.
PloS one 2011;6(7):e22628.
2010: Erin M Clark; Deepa S Joshi; Andrew B Grimm; Avadhut D Joshi; Peng Wang; Shantaram S Joshi
Ultrastructural basis of enhanced antitumor cytotoxicity of cord blood-derived CTLs: a comparative analysis with peripheral blood and bone marrow.
International journal of oncology 2010;37(3):645-53.
2008: Shantaram S Joshi; Amit K Mittal; Peng Wang; Avadhut Joshi; Eileen Vu; Xioujun Wang
Differential gene expression in murine large cell B-cell lymphoma metastatic variants.
International immunopharmacology 2008;8(9):1257-63.
2008: Ganapati V Hegde; Corey M Munger; Katy Emanuel; Avadhut Joshi; Timothy C Greiner; Dennis D Weisenburger; Julie M Vose; Shantaram S Joshi
Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma.
Molecular cancer therapeutics 2008;7(6):1450-60.
2008: Ganapati V Hegde; Erin Meyers-Clark; Shantaram S Joshi; Sam D Sanderson
A conformationally-biased, response-selective agonist of C5a acts as a molecular adjuvant by modulating antigen processing and presentation activities of human dendritic cells.
International immunopharmacology 2008;8(6):819-27.
2007: Amit K Mittal; Ganapati V Hegde; Patricia Aoun; R Gregory Bociek; Bhavana J Dave; Avadhut Joshi; Warren G Sanger; Dennis D Weisenburger; Shantaram S Joshi
Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
International journal of molecular medicine 2007;20(4):461-9.
2007: Avadhut Joshi; Ganapati V Hegde; John D Dickinson; Amit K Mittal; James C Lynch; James D Eudy; James O Armitage; Philip J Bierman; R Gregory Bociek; Marcel P Devetten; Julie M Vose; Shantaram S Joshi
ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5295-304.
2007: Maram K Reddy; Jaspreet K Vasir; Ganapati V Hegde; Shantaram S Joshi; Vinod Labhasetwar
Erythropoietin induces excessive neointima formation: a study in a rat carotid artery model of vascular injury.
Journal of cardiovascular pharmacology and therapeutics 2007;12(3):237-47.
2007: Avadhut Joshi; Erin M Clark; Peng Wang; Corey M Munger; Ganapati V Hegde; Sam Sanderson; Harish P Dave; Shantaram S Joshi
Immunotherapy of human neuroblastoma using umbilical cord blood-derived effector cells.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2007;2(2):202-12.
2007: Avadhut Joshi; John D Dickinson; Ganapati V Hegde; Warren G Sanger; James O Armitage; Philip J Bierman; R Gregory Bociek; Marcel P Devetten; Julie M Vose; Shantaram S Joshi
Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.
Cancer genetics and cytogenetics 2007;172(2):120-6.
2006: Dhrubajyoti Chakravarti; Muhammad Zahid; Matthew Backora; Erin M Myers; Nilesh W Gaikwad; Dennis D Weisenburger; Ercole L Cavalieri; Eleanor G Rogan; Shantaram S Joshi
Ortho-quinones of benzene and estrogens induce hyperproliferation of human peripheral blood mononuclear cells.
Leukemia & lymphoma 2006;47(12):2635-44.
2006: Corey M Munger; Julie M Vose; Shantaram S Joshi
Dendritic cell-based therapy for mantle cell lymphoma.
International journal of oncology 2006;28(6):1337-43.
2006: John D Dickinson; Avadhut Joshi; Javeed Iqbal; Warren G Sanger; Philip J Bierman; Shantaram S Joshi
Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
International journal of molecular medicine 2006;17(5):769-78.
2006: John D Dickinson; Jamie Gilmore; Javeed Iqbal; Warren G Sanger; James C Lynch; John Chan; Philip J Bierman; Shantaram S Joshi
11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules.
Leukemia & lymphoma 2006;47(2):231-44.
2005: John D Dickinson; Lynette M Smith; Warren G Sanger; Guimei Zhou; Peter Townley; James C Lynch; Z Steven Pavletic; Philip J Bierman; Shantaram S Joshi
Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia.
British journal of haematology 2005;128(4):460-71.
2004: Peng Wang; Corey M Munger; Avadhut Joshi; Samuel J Pirruccello; Shantaram S Joshi
Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo.
Breast cancer research and treatment 2004;83(1):15-23.
2003: Steven Z Pavletic; R Gregory Bociek; James M Foran; Ronald J Rubocki; Charles A Kuszynski; James L Wisecarver; Lori Hatcher; David M Lucas; John C Byrd; Michael R Grever; Shantaram S Joshi; Penny Hardiman; Lynette M Smith; Timothy R McGuire; Philip J Bierman; Julie M Vose; James O Armitage; James Edward Talmadge
Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation.
Transplantation 2003;76(5):877-81.
2003: Shantaram S Joshi; Michael Bishop; James C Lynch; stefano r tarantolo; Sunil Abhyankar; Philip J Bierman; Julie M Vose; RB Geller; Joseph P McGuirk; James M Foran; R Gregory Bociek; A Hadi; S D Day; James O Armitage; Anne Kessinger; Z Steven Pavletic
Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
Cytotherapy 2003;5(6):542-52.
2002: Todd R Lovgren; stefano r tarantolo; Cody Evans; Charles A Kuszynski; Shantaram S Joshi
Enhanced in vitro and in vivo cytotoxicity of umbilical cord blood cells against human breast cancer following activation with IL-15 and colony stimulating factors.
In vivo (Athens, Greece) 2002;16(6):541-50.
2002: Peng Wang; Z Steven Pavletic; Shantaram S Joshi
Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.
Leukemia & lymphoma 2002;43(9):1827-35.
2002: Shantaram S Joshi; U Eileen Vu; Todd R Lovgren; Margaret Lorkovic; Wayshalee Patel; Gordon L Todd; Charles A Kuszynski; Bharathi J Joshi; Harish P Dave
Comparison of phenotypic and functional dendritic cells derived from human umbilical cord blood and peripheral blood mononuclear cells.
Journal of hematotherapy & stem cell research 2002;11(2):337-47.
2001: Shantaram S Joshi; James C Lynch; Steven Z Pavletic; stefano r tarantolo; Samuel J Pirruccello; Anne Kessinger; Michael Bishop
Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics.
Blood 2001;98(6):1963-70.
2001: Manashi Bagchi; Charles A Kuszynski; Jaya Balmoori; Shantaram S Joshi; Sidney J Stohs; DEBASIS BAGCHI
Protective effects of antioxidants against smokeless tobacco-induced oxidative stress and modulation of Bcl-2 and p53 genes in human oral keratinocytes.
Free radical research 2001;35(2):181-94.
2001: J Graham Sharp; Michael Bishop; B Copple; Timothy C Greiner; Patrick L Iversen; John D Jackson; Shantaram S Joshi; Eric J Benner; SL Mann; A K Rao; Julie M Vose
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells.
Leukemia & lymphoma 2001;42(3):417-27.
2001: Shantaram S Joshi; Charles A Kuszynski; DEBASIS BAGCHI
The cellular and molecular basis of health benefits of grape seed proanthocyanidin extract.
Current pharmaceutical biotechnology 2001;2(2):187-200.
2000: J Graham Sharp; Anne Kessinger; James C Lynch; Z Steven Pavletic; Shantaram S Joshi
Blood stem cell transplantation: factors influencing cellular immunological reconstitution.
Journal of hematotherapy & stem cell research 2000;9(6):971-81.
2000: Shantaram S Joshi; Charles A Kuszynski; Manashi Bagchi; DEBASIS BAGCHI
Chemopreventive effects of grape seed proanthocyanidin extract on Chang liver cells.
Toxicology 2000;155(1-3):83-90.
2000: U E Vu; Z Steven Pavletic; Xiaoxia Wang; Shantaram S Joshi
Increased cytotoxicity against B-chronic lymphocytic leukemia by cellular manipulations: potentials for therapeutic use.
Leukemia & lymphoma 2000;39(5-6):573-82.
2000: Shantaram S Joshi; stefano r tarantolo; Charles A Kuszynski; Anne Kessinger
Antitumor therapeutic potential of activated human umbilical cord blood cells against leukemia and breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(11):4351-8.
2000: DEBASIS BAGCHI; Manashi Bagchi; Sidney J Stohs; Dipak K Das; Sidhartha D Ray; Charles A Kuszynski; Shantaram S Joshi; H G Pruess
Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention.
Toxicology 2000;148(2-3):187-97.
2000: C Liu; E S Ferdinandi; G Ely; Shantaram S Joshi
Virulizin-2gamma, a novel immunotherapeutic agent, in treatment of human pancreatic cancer xenografts.
International journal of oncology 2000;16(5):1015-20.
2000: John E Mata; John D Jackson; Shantaram S Joshi; WG Tracewell; Samuel J Pirruccello; Brian J Murphy; Michael Bishop; Patrick L Iversen
Pharmacokinetics and in vivo effects of a six-base phosphorothioate oligodeoxynucleotide with anticancer and hematopoietic activities in swine.
Journal of hematotherapy & stem cell research 2000;9(2):205-14.
2000: Shantaram S Joshi; K Miller; John D Jackson; Phyllis I Warkentin; Anne Kessinger
Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients.
Cytotherapy 2000;2(1):15-24.
2000: DEBASIS BAGCHI; Shantaram S Joshi; Manashi Bagchi; Jaya Balmoori; Eric J Benner; Charles A Kuszynski; Sidney J Stohs
Cadmium- and chromium-induced oxidative stress, DNA damage, and apoptotic cell death in cultured human chronic myelogenous leukemic K562 cells, promyelocytic leukemic HL-60 cells, and normal human peripheral blood mononuclear cells.
Journal of biochemical and molecular toxicology 2000;14(1):33-41.
1999: Xumein Ye; Roger L Krohn; W Liu; Shantaram S Joshi; Charles A Kuszynski; Thomas R McGinn; Manashi Bagchi; Harry G Preuss; Sidney J Stohs; DEBASIS BAGCHI
The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells.
Molecular and cellular biochemistry 1999;196(1-2):99-108.
1999: Shantaram S Joshi; Charles A Kuszynski; Eric J Benner; Manashi Bagchi; DEBASIS BAGCHI
Amelioration of the cytotoxic effects of chemotherapeutic agents by grape seed proanthocyanidin extract.
Antioxidants & redox signaling 1999;1(4):563-70.
1998: Shantaram S Joshi; N N Babushkina-Patz; D J Verbik; Thomas G Gross; stefano r tarantolo; Charles A Kuszynski; Samuel J Pirruccello; Michael Bishop; Anne Kessinger
Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cells.
International journal of oncology 1998;13(4):791-9.
1998: MH Schneiderman; John D Jackson; Shantaram S Joshi; L Clark-Pierce; Brian J Murphy; G S Schneiderman
Cell cycle-based purging of lymphoma cells from bone marrow harvests using radioiodinated 5-iodo-2'-deoxyuridine.
Radiation research 1998;149(2):147-54.
1998: Z Steven Pavletic; Shantaram S Joshi; Samuel J Pirruccello; stefano r tarantolo; JP Kollath; Elizabeth C Reed; Philip J Bierman; Julie M Vose; Phyllis I Warkentin; Thomas G Gross; K Nasrati; James O Armitage; Anne Kessinger; Michael Bishop
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies.
Bone marrow transplantation 1998;21(1):33-41.
1997: Eric J Benner; Michael Bishop; N Agarwal; P Iversen; Shantaram S Joshi
Combination of antisense oligonucleotide and low-dose chemotherapy in hematological malignancies.
Journal of pharmacological and toxicological methods 1997;37(4):229-35.
1997: SL Mann; Shantaram S Joshi; D A Crouse; James O Armitage; Anne Kessinger; Dennis D Weisenburger; W P Vaughan; J Graham Sharp
Increased hematopoietic progenitor cell maintenance in long-term bone marrow cultures containing minimal numbers of contaminating breast cancer cells.
Breast cancer research and treatment 1997;44(2):115-21.
1997: John E Mata; Shantaram S Joshi; B Palen; Samuel J Pirruccello; John D Jackson; N Elias; Todd Page; K L Medlin; Patrick L Iversen
A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo.
Toxicology and applied pharmacology 1997;144(1):189-97.
1997: W Hao; L Messbarger; Shantaram S Joshi
Immunosuppression by metastatic lymphoma derived altered retroviral gp70 molecule.
Leukemia 1997;11 Suppl 3():202-5.
1996: D J Verbik; W W Stinson; M J Brunda; Anne Kessinger; Shantaram S Joshi
In vivo therapeutic effects of interleukin-12 against highly metastatic residual lymphoma.
Clinical & experimental metastasis 1996;14(3):219-29.
1995: J Graham Sharp; M Bishop; Wing C Chan; T Greiner; Shantaram S Joshi; Anne Kessinger; E Reed; Warren G Sanger; stefano r tarantolo; M Traystman
Detection of minimal residual disease in hematopoietic tissues.
Annals of the New York Academy of Sciences 1995;770():242-61.
1995: A G Wu; Shantaram S Joshi; Wing C Chan; Patrick L Iversen; John D Jackson; Anne Kessinger; Samuel J Pirruccello; Warren G Sanger; J Graham Sharp; D J Verbik
Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
Leukemia & lymphoma 1995;20(1-2):67-76.
1995: Shantaram S Joshi; J Connolly; SL Mann; J Graham Sharp
Altered in vivo and in vitro behavior of butanol-modified bone marrow cells.
Experimental hematology 1995;23(12):1284-8.
1995: K C Komanduri; D J Tomes; Hans-Joachim Gabius; Shantaram S Joshi
Macrophage-like-cell-induced growth regulation of lymphoma cells.
Oncology 1995;52(3):196-201.
1995: D J Verbik; John D Jackson; Samuel J Pirruccello; K D Patil; Anne Kessinger; Shantaram S Joshi
Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections.
Blood 1995;85(7):1964-70.
1994: Shantaram S Joshi; L J Messbarger; W Hao
Interleukin-2 therapy of lymphoma-bearing immunosuppressed mice.
Clinical & experimental metastasis 1994;12(1):37-46.
1993: S K Saxena; J S Thompson; Shantaram S Joshi; J G Sharp
Extent and role of urogastrone in the adaptive response of rat intestine to patching of a surgical defect in the ileum.
Journal of investigative surgery : the official journal of the Academy of Surgical Research 1993;6(6):485-92.
1993: W Hao; Thomas L McDonald; K W Brunson; Shantaram S Joshi
Enhanced immunosuppressive activity associated with metastatic lymphoma cells.
Cancer research 1993;53(8):1921-8.
1992: J Graham Sharp; Shantaram S Joshi; James O Armitage; Philip J Bierman; Peter F Coccia; D S Harrington; Anne Kessinger; D A Crouse; SL Mann; Dennis D Weisenburger
Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique.
Blood 1992;79(4):1074-80.
1992: S K Saxena; J S Thompson; Shantaram S Joshi; J Graham Sharp
Association of radiolabeled urogastrone binding with regenerating intestinal mucosa and epidermal growth factor/urogastrone producing organs in rat.
Life sciences 1992;51(5):381-7.
1992: Shantaram S Joshi; SL Mann; Margaret A Tempero; D A Crouse; R A Stratbucker; M A Quaife; J Graham Sharp
Quantitation of metastatic tumor burden from human colon tumor xenografts using radiolabelled monoclonal antibody 17-A fragments.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1992;13(4):195-206.
1991: Shantaram S Joshi; J M DeBoer; S J Strandjord; Samuel J Pirruccello; Warren G Sanger; Dennis D Weisenburger; J Graham Sharp
Characterization of a newly established human Burkitt's lymphoma cell line, OMA-BL-1.
International journal of cancer. Journal international du cancer 1991;47(5):643-8.
1991: Shantaram S Joshi; S J O'Connor; D D Weisenburger; J G Sharp; H M Gharpure; K W Brunson
Enhanced antiproliferative activity by metastatic RAW117 lymphoma cells.
Clinical & experimental metastasis 1991;9(1):27-37.
1991: Sidney S Mirvish; J Nickols; D D Weisenburger; D Johnson; Shantaram S Joshi; P Kaplan; M Gross; H Y Tong
Effects of 2,4,5-trichlorophenoxyacetic acid, pentachlorophenol, methylprednisolone, and Freund's adjuvant on 2-hydroxyethylnitrosourea carcinogenesis in MRC-Wistar rats.
Journal of toxicology and environmental health 1991;32(1):59-74.
1990: Sidney S Mirvish; D D Weisenburger; Shantaram S Joshi; J Nickols
2-Hydroxyethylnitrosourea induction of B cell lymphoma in female Swiss mice.
Cancer letters 1990;54(1-2):101-6.
1990: Shantaram S Joshi; D J Novak; L Messbarger; V Maitreyan; Dennis D Weisenburger; J Graham Sharp
Levels of detection of tumor cells in human bone marrow with or without prior culture.
Bone marrow transplantation 1990;6(3):179-83.
1990: W M Hao; Shantaram S Joshi
Differential susceptibility of metastatic lymphoma cells to natural immunity.
Oncology 1990;47(6):483-7.
1990: Shantaram S Joshi; K W Brunson
Differential cell surface antigen expression on metastatic variant lymphoma cell lines.
Oncology 1990;47(4):339-43.
1990: R Alter; Shantaram S Joshi; J D Verdirame; Dennis D Weisenburger
Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin.
Leukemia research 1990;14(3):279-86.
1989: Shantaram S Joshi; J D Jackson; J Graham Sharp
Comparison of the growth and metastasis of four human intestinal tumor cell line xenografts.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1989;10(3):117-25.
1988: W P Vaughan; Curt I Civin; Dennis D Weisenburger; Judith E Karp; M L Graham; Warren G Sanger; H L Grierson; Shantaram S Joshi; P J Burke
Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10).
Leukemia 1988;2(10):661-6.
1988: Shantaram S Joshi; F Sinangil; J G Sharp; N B Mathews; D J Volsky; K W Brunson
Effects of differentiation inducing chemicals on in vivo malignancy and NK susceptibility of metastatic lymphoma cells.
Cancer detection and prevention 1988;11(3-6):405-17.
1988: Shantaram S Joshi; L D Glenn; W P Vaughan; Mario Stevenson; Warren G Sanger; J Graham Sharp; Dennis D Weisenburger
Preferential in-vitro growth and expansion of leukemic T lymphoblasts.
Leukemia research 1988;12(2):103-8.
1987: Shantaram S Joshi; P A Tilden; J D Jackson; J G Sharp; K W Brunson
Cell surface properties associated with malignancy of metastatic large cell lymphoma cells.
Cancer research 1987;47(13):3551-7.
1987: Shantaram S Joshi; Anne Kessinger; SL Mann; Mario Stevenson; Dennis D Weisenburger; W P Vaughan; James O Armitage; J Graham Sharp
Detection of malignant cells in histologically normal bone marrow using culture techniques.
Bone marrow transplantation 1987;1(3):303-10.
1987: Shantaram S Joshi; J G Sharp; K W Brunson
Differential growth characteristics of low and high metastatic variant RAW117 murine lymphosarcoma cells.
Oncology 1987;44(3):180-5.
1987: Shantaram S Joshi; J G Sharp; H M Gharpure; K W Brunson
Characterization of metastasis-associated antigens on RAW117 lymphosarcoma cell lines.
Clinical & experimental metastasis 1987;5(1):89-104.